Clinical and Economic Outcomes of Continuous Glucose Monitoring System (CGMS) in Patients with Diabetes Mellitus: A Systematic Literature Review - Diabetes Research and Clinical Practice
![Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach | [current-page:pager]touchENDOCRINOLOGY](https://www.touchendocrinology.com/wp-content/uploads/sites/5/2018/02/table1-summary-of-char.png "Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach | [current-page:pager]touchENDOCRINOLOGY")
Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach | [current-page:pager]touchENDOCRINOLOGY
Endoscopic transmission of carbapenem-resistant Enterobacteriaceae: implications for U.S. Food and Drug Administration approval and postmarket surveillance of endoscopic devices - Gastrointestinal Endoscopy
Compassionate use of drugs and medical devices in the United States, the European Union and Japan. - Abstract - Europe PMC
The relevance of skull density ratio in selecting candidates for transcranial MR-guided focused ultrasound in: Journal of Neurosurgery Volume 132 Issue 6 (2019) Journals
Impact of Balloon Predilatation on Hemodynamics and Outcomes After Transcatheter Aortic Valve Implantation With the Self-Expanding CoreValve Prosthesis - American Journal of Cardiology
Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma - Cognetti - 2021 - Head & Neck - Wiley Online Library
Current perspectives on the US FDA regulatory framework for intelligent drug-delivery systems | Therapeutic Delivery
PDF) Lack of Publicly Available Scientific Evidence on the Safety and Effectiveness of Implanted Medical Devices
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus - Endocrine Practice
An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials | NEJM
Bayesian statistical method was underused despite its advantages in the assessment of implantable medical devices - Journal of Clinical Epidemiology
Current perspectives on the US FDA regulatory framework for intelligent drug-delivery systems | Therapeutic Delivery
PDF) Continuous glucose monitoring devices: A brief presentation (Review)
Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Systematic Review and Meta-Analysis | JACC: Clinical Electrophysiology
Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions | Circulation: Cardiovascular Interventions
An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials | NEJM
100 years of insulin: celebrating the past, present and future of diabetes therapy | Nature Medicine
Technological innovation of Continuous Glucose Monitoring (CGM) as a tool for commercial aviation pilots with insulin-treated diabetes and stakeholders/regulators: A new chance to improve the directives? - Diabetes Research and Clinical Practice
Hot Topics in FDA Law Contact: Barbara Evans, Office BLB 214
Frontiers | Advancing Regulatory Science With Computational Modeling for Medical Devices at the FDA's Office of Science and Engineering Laboratories | Medicine
